Moptim completes nearly RMB 100 million Series B financing to drive ophthalmic innovation and global expansion

Recently, Moptim announced the completion of nearly RMB 100 million in Series B financing. This round was led by China Venture Capital, with existing shareholders CAS Capital and Baidu Venture Capital making additional follow-on investments that exceeded their previous commitments. The proceeds from this round will be used to iterate core underlying optical technologies, expand high-end intelligent manufacturing capacity, upgrade AI algorithms, and comprehensively promote the large-scale deployment of the company's products in both China's primary healthcare market and global markets. Through hardcore technology, Moptim aims to support the national initiative to strengthen the foundation of medical care and drive China's high-end ophthalmic instruments to the world.

Following this financing round, Moptim will focus on high-quality development in three key directions:

Advancing Core Technologies: Continuously making breakthroughs in key capabilities such as high resolution, high-speed scanning, and AI-assisted analysis, while consolidating China's independent core technological barriers.

Expanding High-End Intelligent Manufacturing: Enhancing global supply chain stability and delivery capabilities to support the simultaneous growth of China's primary healthcare market and global markets.

Globalizing its Footprint: Improving overseas and domestic distribution channels and technical service systems to build a worldwide clinical support and market network.

Looking toward the 15th Five-Year Plan period, Moptim will remain true to its original aspiration of leveraging technology for good and benefiting all people. Through independent innovation, the company will tackle industry challenges and serve public health with hardcore products. Moptim will steadily advance the globalization of China's high-end ophthalmic instruments, empowering the global eye health endeavor with Chinese technology, Chinese solutions, and Chinese standards. Moptim is committed to contributing to the national initiative of strengthening the foundation of medical care, the construction of a Healthy China, and the vision of a global community of health for all.